E. Schachner-Wünschmann

  • Citations Per Year
Learn More
Continuous administration of gonadotrophin-releasing hormone (GnRH-)analogues leads to a receptor-down regulation of pituitary GnRH-receptors and subsequently inhibits ovarian hormone production. Since October, 1984, 118 evaluable pre- and perimenopausal patients (median age 42, range 25-55 years) with metastatic breast cancer were entered into an open(More)
Eighty patients with different stages of genital endometriosis were treated with Zoladex, a gonadotrophin-releasing hormone analogue in a depot formulation, injected subcutaneously every 4 weeks. The stages of endometriosis (I-IV) were classified according to the revised American Fertility Society recommendations (AFS criteria) via pelviscopy before and(More)
Es ist allgemein akzeptiert, dab die hemmende Wirkung Tamoxifens auf das Wachstum von Tumorzellen durch den Ostrogenrezeptor (ER) vermittelt wird. Das Ansprechen einiger Mammakarzinompatientinnen mit ER-negativen Tumoten auf Tamoxifentherapie und in vitro Experimente deuten jedoch auf m6gliche Wirkungsmechanismen der Anti6strogene unabh/ingig vom ER bin.(More)
  • 1